Belcaro, Gianni, Hosoi, Morio, Feragalli, Beatrice et al. · Minerva medica · 2018 · DOI
This study tested whether a supplement called Robuvit® (made from French oak wood) could help people with burnout syndrome who experience severe fatigue and high oxidative stress (a type of cellular damage). Over 4 weeks, people taking Robuvit® showed improvements in emotional exhaustion, job satisfaction, and stress levels compared to those receiving standard treatment alone. The supplement also reduced markers of oxidative stress in the blood.
ME/CFS patients often experience severe fatigue, emotional exhaustion, and elevated oxidative stress similar to those in this burnout cohort. Understanding whether Robuvit® can reduce both fatigue and oxidative stress could offer a potential therapeutic avenue for patients with ME/CFS. This study bridges occupational burnout and chronic fatigue, suggesting common pathophysiological mechanisms related to oxidative stress.
This study does not prove Robuvit® is effective for ME/CFS specifically—the population studied was occupational burnout cases, which may differ mechanistically from post-viral fatigue syndromes. The registry design without clear randomization or blinding cannot establish causation, only association. The study also does not demonstrate whether improvements in oxidative stress markers directly cause symptom improvement or represent an epiphenomenon.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →